Does TRASTUZUMAB Cause Neoplasm malignant? 155 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 155 reports of Neoplasm malignant have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.3% of all adverse event reports for TRASTUZUMAB.
155
Reports of Neoplasm malignant with TRASTUZUMAB
0.3%
of all TRASTUZUMAB reports
88
Deaths
11
Hospitalizations
How Dangerous Is Neoplasm malignant From TRASTUZUMAB?
Of the 155 reports, 88 (56.8%) resulted in death, 11 (7.1%) required hospitalization, and 2 (1.3%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 155 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB Cause?
Diarrhoea (4,996)
Off label use (3,802)
Nausea (3,499)
Fatigue (3,417)
Myelosuppression (2,552)
Disease progression (2,449)
Death (2,378)
Vomiting (2,244)
Dyspnoea (2,010)
Pyrexia (1,886)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TRASTUZUMAB Alternatives Have Lower Neoplasm malignant Risk?
TRASTUZUMAB vs TRASTUZUMAB-ANNS
TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN
TRASTUZUMAB vs TRASTUZUMAB-DKST
TRASTUZUMAB vs TRASTUZUMAB-DTTB
TRASTUZUMAB vs TRASTUZUMAB EMTANSINE